Polomar Health Services, Inc.

Polomar Health Services, Inc. is a U.S.-based pharmaceutical preparations company that appears to operate through product fulfillment, distribution, pharmacy services, and compounding-related agreements. The company’s filings indicate a business built around healthcare product and service delivery arrangements rather than a broad consumer brand portfolio.

−119,9 %

71,0 %

−1 650,8 %

+1 002,0 %

0.20

0.14

— Polomar Health Services, Inc.
	%
Product Fulfillment and Distribution	45% Arrangement-based fulfillment and distribution of healthcare-related products.
Pharmacy Services	25% Pharmacy service offerings tied to healthcare product delivery and support.
Compounding Services	15% Custom compounding and related preparation services for healthcare use.
Professional and Administrative Services	15% Contracted services supporting operations, commercialization, and execution.

The company’s customers appear to be healthcare and life-science counterparties that need fulfillment, distribution,...

Healthcare product and service partnersprimary
Buy fulfillment, distribution, and related support services to move healthcare products through the supply chain.
Pharmacy and compounding customersprimary
Use pharmacy services and compounding capabilities for specialized preparation and dispensing needs.
Contracting counterpartiessecondary
Enter service and supply agreements that define the company’s operating revenue base.

Polomar Health Services is organized as a U.S. company, and the available filings do not disclose a meaningful...

•United States is the company’s home market and operating base
•No country-level revenue disclosure was provided in the excerpts
•Business appears centered on domestic healthcare counterparties
•Geographic concentration likely matters because operations are U.S.-regulated

The company’s disclosed agreements point to a strategy centered on building contracted healthcare service relationships...

Deepen contracted healthcare service relationshipsshort-term

Contracted arrangements provide the operating base and visibility for a small healthcare services platform.

Broaden service scope across fulfillment, pharmacy, and compoundingmedium-term

A wider service mix can increase customer stickiness and reduce dependence on any single arrangement.

The company appears exposed to contract concentration, execution risk, and regulatory oversight typical of...

high

Customer and contract concentration

The disclosed business is built around specific agreements, so loss or non-renewal of a key contract could reduce activity quickly.

Scope: Revenue and operating scale
Materiality: high

high

Regulatory and compliance risk

Pharmaceutical preparations, pharmacy services, and compounding are subject to healthcare regulation and oversight.

Scope: Licensing, operations, product handling
Materiality: high

medium

Execution and service quality risk

Fulfillment and distribution businesses depend on accurate, timely, and compliant execution across the supply chain.

Scope: Customer retention and liability
Materiality: medium

medium

Counterparty and financing risk

The filings reference promissory notes and loan agreements, indicating reliance on external funding relationships.

Scope: Liquidity and covenant-like obligations
Materiality: medium

Revenue recognition on service contracts

Affects reported revenue timing and comparability across periods

Receivables and credit losses

Affects operating results through bad-debt expense

Debt and related financing disclosures

Affects leverage presentation and cash flow obligations

Polomar Health Services, Inc.

Customer and contract concentration

Regulatory and compliance risk

Execution and service quality risk

Counterparty and financing risk

Palomar Holdings, Inc.

Zicix Corp

PACIFIC HEALTH CARE ORGANIZATION INC

P3 Health Partners Inc.

Telomir Pharmaceuticals, Inc.

Elite Health Systems Inc.